Vincent Le Moing

9.9k total citations · 2 hit papers
137 papers, 3.8k citations indexed

About

Vincent Le Moing is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Vincent Le Moing has authored 137 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Infectious Diseases, 61 papers in Epidemiology and 29 papers in Virology. Recurrent topics in Vincent Le Moing's work include HIV/AIDS drug development and treatment (35 papers), HIV/AIDS Research and Interventions (32 papers) and HIV Research and Treatment (29 papers). Vincent Le Moing is often cited by papers focused on HIV/AIDS drug development and treatment (35 papers), HIV/AIDS Research and Interventions (32 papers) and HIV Research and Treatment (29 papers). Vincent Le Moing collaborates with scholars based in France, United States and Canada. Vincent Le Moing's co-authors include Xavier Duval, Catherine Chirouze, Catherine Leport, François Delahaye, Geneviève Chêne, François Alla, Bruno Hoen, François Raffi, Thanh Doco‐Lecompte and Bernard Iung and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Vincent Le Moing

128 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey

2012 445 citations Christine Selton‐Suty, M. Célard et al. profile →
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

2014 315 citations Vincent Le Moing, Catherine Chirouze et al. profile →

Peers

Countries citing papers authored by Vincent Le Moing

Since Specialization

Citations

This map shows the geographic impact of Vincent Le Moing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Le Moing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Le Moing more than expected).

Fields of papers citing papers by Vincent Le Moing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Le Moing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Le Moing. The network helps show where Vincent Le Moing may publish in the future.

Co-authorship network of co-authors of Vincent Le Moing

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Le Moing. A scholar is included among the top collaborators of Vincent Le Moing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Le Moing. Vincent Le Moing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE 2025 ·Infectious Diseases Now ·Lionel Piroth, Virginie Vitrat, Vincent Le Moing, Philippe Bret, Y. Brault, W. F. Greenwood, Marie‐Charlotte Chopin, Éric Vicaut, Philippe Montravers, (unknown), Alexandre Bleibtreu	0
2	Seoul Virus Infection and Subsequent Guillain-Barré Syndrome in Traveler Returning to France from Kenya, 2022 2025 ·Emerging infectious diseases ·(unknown), Charlotte Boullé, Vincent Le Moing, Vincent Foulongne, Virginie Sauvage	0
3	Characteristics, management, and outcome of tuberculosis after liver transplant: A case series and literature review 2024 ·Infectious Diseases Now ·(unknown), Pauline Houssel‐Debry, (unknown), Jérôme Dumortier, Anne Pouvaret, (unknown), François Danion, Laure Surgers, Vincent Le Moing, Nassim Kamar, Fanny Lanternier, Pierre Tattevin	1
4	Cerebral vasculitis as a complication of pneumococcal meningitis: A cohort study 2023 ·Infectious Diseases Now ·(unknown), (unknown), Caroline Arquizan, Éric Thouvenot, Paul Loubet, Vincent Le Moing, Marie‐Christine Picot, Alain Makinson	1
5	Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019 2022 ·The Journal of Infectious Diseases ·(unknown), Amandine Pisoni, (unknown), Karine Bolloré, Anne‐Sophie Bedin, Alain Makinson, (unknown), (unknown), (unknown), Vincent Le Moing, Philippe Van de Perre, Édouard Tuaillon	6
6	Is blood lymphocyte count a prognostic biomarker in Staphylococcus aureus bacteremia? 2022 ·Journal of Investigative Medicine ·Mathieu Blot, (unknown), Serge Aho, (unknown), Vincent Le Moing, Catherine Chirouze, Kévin Bouiller, Lionel Piroth	3
7	Toxoplasmose aiguë multiviscérale de l'immunocompétent : à propos d'un cas importé d'Afrique tropicale 2022 ·(unknown), (unknown), (unknown), Vincent Le Moing	2
8	COVID-19: The forgotten cases of hidden exiles 2021 ·Infectious Diseases Now ·Christine Le Bihan-Benjamin, (unknown), Vincent Le Moing, (unknown), (unknown), (unknown), (unknown), (unknown), Alain Makinson	3
9	Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results 2017 ·Journal of the International AIDS Society ·Laura Ciaffi, (unknown), (unknown), (unknown), Sabrina Eymard‐Duvernay, Suzanne Izard, Vincent Le Moing, Jacques Zoungrana, (unknown), Charles Kouanfack, (unknown), Ndèye Fatou Ngom Gueye, (unknown), Guillaume Bado, Katie Kane, Avelin F. Aghokeng, Martine Peeters, Jacques Reynes, Éric Delaporte	1
10	Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis 2016 ·PLoS ONE ·Christine Selton‐Suty, François Delahaye, (unknown), (unknown), Vincent Le Moing, Catherine Chirouze, Pierre Nazeyrollas, Véronique Vernet-Garnier, Yvette Bernard, Sidney Chocron, Jean‐François Obadia, François Alla, Bruno Hoen, Xavier Duval	27
11	Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial 2016 ·Journal of the International AIDS Society ·Laura Ciaffi, Sinata Koulla‐Shiro, (unknown), Ndèye Fatou Ngom Gueye, Vincent Le Moing, Sabrina Eymard‐Duvernay, Suzanne Izard, Jacques Zoungrana, (unknown), (unknown), Guillaume Bado, Katie Kane, Avelin F. Aghokeng, Martine Peeters, Jacques Reynes, Éric Delaporte	2
12	The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia 2016 ·Journal of Infection ·Sarah Tubiana, Xavier Duval, François Alla, Christine Selton‐Suty, Pierre Tattevin, François Delahaye, Lionel Piroth, Catherine Chirouze, Jean‐Philippe Lavigne, Marie‐Line Erpelding, Bruno Hoen, François Vandenesch, Bernard Iung, Vincent Le Moing	73
13	Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study 2015 ·PLoS ONE ·Vincent Le Moing, François Alla, Thanh Doco‐Lecompte, François Delahaye, Lionel Piroth, Catherine Chirouze, (unknown), Jean‐Philippe Lavigne, Marie‐Line Erpelding, Bruno Hoen, François Vandenesch, Xavier Duval, (unknown)	64
14	Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients 2015 ·AIDS ·Mathias Bruyand, (unknown), A. Lavolé, Karen Leffondré, Jean Philippe Spano, Vincent Le Moing, (unknown), Laura March, Jacquès Cadranel, Fabrice Bonnet, Marguerite Guiguet	7
15	Human Immunodeficiency Virus Infection and Non-small Cell Lung Cancer: Survival and Toxicity of Antineoplastic Chemotherapy in a Cohort Study 2011 ·Journal of Thoracic Oncology ·Alain Makinson, (unknown), Sabrina Eymard‐Duvernay, Jean-Louis Pujol, Clotilde Allavena, Lise Cuzin, Isabelle Poizot‐Martin, X. de la Tribonnière, André Cabié, Pascal Puglièse, Jacques Reynes, Vincent Le Moing	34
16	Characteristics and regional variations of group D streptococcal endocarditis in France 2007 ·Clinical Microbiology and Infection ·Efthymia Giannitsioti, Catherine Chirouze, (unknown), I. Béguinot, François Delahaye, Jean‐Luc Mainardi, M. Célard, (unknown), Vincent Le Moing, Bruno Hoen	37
17	Plasma Levels of Indinavir and Nelfinavir at Time of Virologic Response May Have a Different Impact on the Risk of Further Virologic Failure in HIV-Infected Patients 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Vincent Le Moing, Gilles Peytavin, Valérie Journot, Jacqueline Cottalorda, E Bouvet, Geneviève Chêne, Marie Préau, Corinne Merle De Boever, Catherine Leport, François Raffi	7
18	Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen 2002 ·AIDS ·Vincent Le Moing, Geneviève Chêne, Patrizia Carrieri, Ahmadou Alioum, Françoise Brun‐Vézinet, Lionel Piroth, (unknown), Jean‐Paul Moatti, François Raffi, Catherine Leport	141
19	De nouveaux antiviraux pour les viroses respiratoires 1999 ·La Presse Médicale ·Vincent Le Moing	1
20	Prévention de l’endocardite infectieuse 1997 ·Vincent Le Moing, Catherine Leport	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact